SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$31.43−0.81 (-2.50%)
Close on Nov 17, 2026Market cap $1.05BP/E –Yield –
SpyGlass Pharma operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$41.45M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$41.45M | – |
| FY2024 | Dec 31, 2024 | -$27.06M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$21.97M | – |
| Q1 FY2026 | Mar 31, 2026 | -$15.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.30M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.42M | – |
See a number that looks wrong?